<DOC>
	<DOC>NCT00563017</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy, tolerability and safety of patients on long-acting Risperidone microshpheres injection. The major advantage of long-acting injection over oral medication is facilitation of compliance in medication taking. Non-compliance is very common among schizophrenic and is a frequent cause of relapse.</brief_summary>
	<brief_title>Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Catatonia</mesh_term>
	<mesh_term>Schizophrenia, Disorganized</mesh_term>
	<mesh_term>Schizophrenia, Paranoid</mesh_term>
	<mesh_term>Schizophrenia, Catatonic</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Subjects with schizophrenia or another psychotic disorder according to DSM IV criteria who requires long term antipsychotic therapy Currently treated with either an atypical antipsychotic, other than risperidone, a conventional depot antipsychotic or oral conventional antipsychotic Subject has been symptomatically stable on a stable dose of an antipsychotic the last month Subject and/or patient's relative, guardian or legal representative has signed the informed consent form First antipsychotic treatment ever On clozapine during the last 3 month Serious unstable medical condition History or current symptoms of tardive dyskinesia History of neuroleptic malignant syndrome Pregnant or breastfeeding female Female patient of childbearing potential without adequate contraception. Participation in an investigational drug trial in the 30 days prior to selection Known intolerance/nonresponder to risperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Catatonic Schizophrenia</keyword>
	<keyword>Disorganized Schizophrenia</keyword>
	<keyword>Paranoid Schizophrenia</keyword>
	<keyword>Undifferentiated Schizophrenia</keyword>
	<keyword>Schizo-affective disorders</keyword>
</DOC>